Medivolve Inc. — Board/Management Information 2021

Jan 14, 2021

FORM 51-102F3 MATERIAL CHANGE REPORT

Item 1 Name and Address of Company

Medivolve Inc. (“ Medivolve ” or the “ Company ”) 65 Queen Street West Suite 900 Toronto, Ontario M5H 2M5

Item 2 Date of Material Change

January 14, 2021

Item 3 News Release

A news release was issued by the Company through the facilities of GlobeNewswire on January 14, 2021 and was subsequently filed on SEDAR.

Item 4 Summary of Material Change

Medivolve announced the appointment of Dr. Beverley Richardson as a director of the company.

Item 5 Full Description of Material Change

Medivolve announced the appointment of Dr. Beverley Richardson as a director of the company.

The appointment follows the resignation of Danny Callow as a director of the Company.

Item 6 Reliance on subsection 7.1(2) of National Instrument 51-102

Not applicable.

Item 7 Omitted Information

Not applicable.

Item 8 Executive Officer

Aaron Atin Corporate Secretary (416) 861-5888

Item 9 Date of Report

January 14, 2021